Sir, Fabry disease manifesting as chronic uveitisFtreated with enzyme replacement therapy Fabry disease, a metabolic disease, is caused by a-galactosidase A deficiency. 1 Its ophthalmic manifestations include vortex keratopathy, cataract, and retinal vessel tortuosity. 2 We report a case of Fabry disease presenting with chronic uveitis, cystoid macular oedema, and marked visual impairment. It responded only temporarily to periocular steroid injections and was finally stabilized under enzyme replacement therapy (ERT). To our knowledge, these unusual manifestations and the treatment have never been reported. . After 24 weeks of ERT, acroparesthesia, hypohidrosis, and heat intolerance relieved and the uveitis-like picture gradually subsided. Subsequently, he underwent pars plana vitrectomy (OD) for persistent severe vitreous opacity. Postoperatively, the macula showed mottling change without oedema (Figure 2a) . Although no inflammatory signs such as vitreous cells were noted in the left eye, severe vitreous opacity still obscured the fundus and probably affected the vision (Figure 2b) . The latest BCVA was 20/400 (OD) and 20/800 (OS).
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Comment
The most common retinal manifestation of Fabry disease is large vessel tortuosity. 2 In contrast, this case presented with uveitis, vitreous haze, vascular leakage, cystoid Pathology has demonstrated lipid deposition in the vascular smooth muscle cells, the perithelial cells, and the endothelial cells. 3 We believe this may disrupt the blood-ocular barrier, leading to a picture of chronic uveitis. Triamcinolone acetonide has been shown to reduce the breakdown of blood-retinal barrier, 4 introducing the rationale for corticosteroid use in diabetic macular oedema 5 and this case as well. As the effect of periocular steroid was temporary and the ocular manifestations were well controlled after a prolonged course of ERT alone, the concurrence of Fabry disease and other uveitis seems unlikely. ERT has been shown to be effective in clearing lipid deposition in renal microvascular tissue. 1 In this case, ERT may have reduced the lipid deposition in ocular vascular tissue, leading to clinical improvement.
In conclusion, Fabry disease may significantly alter the vascular permeability and present as chronic uveitis. Periocular steroid injection may temporarily reduce vascular permeability and relieve the ocular manifestations. Long-term ERT could relieve the ocular manifestations.
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Case report
A 61-year-old male presented with a history of floaters, blurred vision and discomfort for 1 week in his left eye and 2 days in his right. He had recently been polyuric and had lost 10 kg in weight. He was treated for a urinary tract infection 2 weeks prior to presentation.
Examination found best-corrected visual acuity (BCVA) of 6/60 in each eye. There was bilateral panuveitis, and intraocular pressures were 4 mmHg bilaterally. Retinal haemorrhages were present in the right fundus. The left fundus was not visible; a B-scan showed an attached retina. Blood tests showed raised blood glucose (43.5 mmol/l), and marked neutrophilia (29.8 Â 10 9 /l). A diagnosis of bilateral endogenous bacterial endophthalmitis (EBE) was made. The patient was admitted and intravenous insulin started. Bilateral anterior chamber and vitreous biopsies were performed 
